Related Experiment Video

Updated: Aug 15, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

JAK-STAT pathway in cardiac ischemic stress

Radha Ananthakrishnan1, Kellie Hallam, Qing Li

  • 1Division of Surgical Science, Department of Surgery, College of Physicians and Surgeons 17-401, Columbia University, New York, NY 10032, USA.

Vascular Pharmacology
|November 2, 2005
PubMed

Insights

This review explores the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Cell Signaling

Background:

  • Ischemia-reperfusion injury poses a significant threat to myocardial tissue.
  • Identifying therapeutic targets for myocardial protection is crucial.
  • Signal transduction pathways are key regulators of cellular responses to ischemia.

Purpose of the Study:

  • To review the role of the JAK-STAT pathway in modulating ischemia-reperfusion injury.
  • To explore the mechanisms linking glucose metabolism and angiotensin II to the JAK-STAT pathway in ischemic conditions.
  • To provide a rationale for developing JAK-STAT pathway inhibitors as therapeutic agents.

Main Methods:

  • Literature review of basic and clinical studies.
  • Analysis of signal transduction pathways involved in myocardial ischemia.
  • Exploration of mechanistic links between metabolic and hormonal factors with JAK-STAT signaling.

Main Results:

  • The JAK-STAT pathway plays a critical role in ischemia-reperfusion injury.
  • Glucose metabolism and angiotensin II are implicated in modulating JAK-STAT signaling during ischemia.
  • Evidence supports the JAK-STAT pathway as a viable therapeutic target.

Conclusions:

  • The JAK-STAT pathway is a key modulator of myocardial ischemia-reperfusion injury.
  • Targeting the JAK-STAT pathway offers a promising therapeutic strategy for cardioprotection.
  • Selective JAK-STAT pathway blockers warrant further investigation for clinical application.

More Related Videos

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...